85 patients with advanced ovarian carcinomas were treated either intra-arterially with mtx and 5-fu , later systemically with the cmfv-combination ( therapy arm a ) or only systemically ( therapy arm b ) after randomization .
C0025677
mtx
C0056159
cmfv